Camber Launches Metformin Hydrochloride Oral Solution
Camber Pharmaceuticals, a leader in generic drug approvals and launches, is proud to add Metformin Hydrochloride Oral Solution [met-FOR-min] to its growing portfolio.
Metformin Hydrochloride Oral Solution is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus.
Metformin Hydrochloride Oral Solution is available in 500 mg/5 mL, 16 oz. bottles.
To learn more about this product, please visit: www.camberpharma.com/metformin
Recent articles
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio
- Camber Welcomes Summer 2026 Intern Class
- Camber Launches 5 Generics in May






